Pathological calcification and replicating calcifying-nanoparticles: General approach and correlation

Pediatric Research

Volumn 67, Issue 5, 2010, Pages 490-499

  ÇiftÇioǧlu, Neva ^a   McKay, David S ^a  

^a NASA JOHNSON SPACE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APATITE; CALCIFYING NANOPARTICLE; CALCIUM PHOSPHATE; CRYSTALLIN; NANOPARTICLE; UNCLASSIFIED DRUG;

BIOFILM; CALCIFICATION; HUMAN; KIDNEY POLYCYSTIC DISEASE; NEPHROLITHIASIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCANNING ELECTROCHEMICAL MICROSCOPY; STONE FORMATION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; APATITES; BIOLOGICAL ASSAY; CALCINOSIS; CALCIUM PHOSPHATES; CELLS, CULTURED; CRYSTALLIZATION; HUMANS; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY; PREDICTIVE VALUE OF TESTS;

EID: 77951448562     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181d476ce     Document Type: Review

References (121)

1. Tadic D, Peters F, Epple M 2002 Continuous synthesis of amorphous carbonated apatites. Biomaterials 23:2553-2559 (Pubitemid 34288495)
2. Zaidi AN, Ceneviva GD, Phipps LM, Dettorre MD, Mart CR, Thomas NJ 2005 Myocardial calcification caused by secondary hyperparathyroidism due to dietary deficiency of calcium and vitamin D. Pediatr Cardiol 26:460-463
3. Ray M, Dixit A, Singhi P 2002 Nephrogenic diabetes insipidus with intracranial calcification. Indian Pediatr 39:197-202
4. Carson DA 1998 An infectious origin of extraskeletal calcification. Proc Natl Acad Sci USA 95:7846-7847
5. Pachman LM, Boskey AL 2006 Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis. Curr Rheumatol Rep 8:236-243 (Pubitemid 44623973)
6. Rezaei-Kanavi M, Javadi MA, Mirbabaei-Ghafghazi F 2009 Intraocular lens calcification; a clinicopathologic report. J Ophthalmic Vis Res 4:122-124
7. Peters W, Smith D, Lugowski S, Pritzker K, Holmyard D 2001 Calcification properties of saline-filled breast implants. Plast Reconstr Surg 107:356-363 (Pubitemid 32125277)
8. Pearle MS, Calhourn EA, Curhan GC 2005 Urologic diseases in America project: urolithiasis. J Urol 173:848-857 (Pubitemid 40239354)
9. Stamatelou KK, Francis ME, Jones CA, Curhan GC 2003 Time trends in reported prevalence of kidney stones in the United Sates: 1976-1994. Kidney Int 63:1817-1823
10. Soucie JM, Coates R, McClellan W, Austin H, Thun M 1996 Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol 143:487-495 (Pubitemid 26085079)
11. Brikowski TH, Lotan Y, Pearle MS 2008 Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci USA 105:9841-9846 (Pubitemid 352031387)
12. Evan AP 2009 Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol. Available at: http://www.springerlink.com/content/41507435785w4261/fulltext.pdf. Accessed January 12, 2010
13. Rule AD, Bergstralh EJ, Melton LJ III, Li X, Weaver AL, Lieske JC 2009 Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4:804-811
14. Momohara C, Tsujihata M, Yoshioka I, Tsujimura A, Nonomura N, Okuyama A 2009 Mechanism underlying the low prevalence of pediatric calcium oxalate urolithiasis. J Urol 182:1201-1209
15. Parks JH, Coe FL, Evan AP, Worcester EM 2009 Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant 24:130-136
16. Klee LW, Brito CG, Lingeman JE 1991 The clinical implications of brushite calculi. J Urol 145:715-718
17. El-Abbadi M, Giachelli CM 2005 Arteriosclerosis, calcium phosphate deposition and cardiovascular disease in uremia: current concepts at the bench. Curr Opin Nephrol Hypertens 14:519-524 (Pubitemid 41531841)
18. Levy RJ, Schoen FJ, Anderson HC, Harasaki H, Koch TH, Brown W, Lian JB, Cumming R, Gavin JB 1991 Cardiovascular implant calcification: a survey and update. Biomaterials 12:707-714
19. Demer LL 1995 A skeleton in the atherosclerosis closet. Circulation 92:2029-2032
20. Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, Rumberger J, Stanford W, White R, Taubert K 1996 Coronary artery calcification: pathophysi-ology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. Circulation 94:1175-1192
21. Jono S, Shioi A, Ikari Y, Nishizawa Y 2006 Vascular calcification in chronic kidney disease. J Bone Miner Metab 24:176-181
22. Blair B, Fabrizio M 2000 Pharmacology for renal calculi. Expert Opin Pharmaco-ther 1:435-441
23. Sohshang HL, Singh MA, Singh NG, Singh SR 2000 Biochemical and bacteriological study of urinary calculi. J Commun Dis 32:216-221
24. Driessens FC, Verbeeck RM, van Dijk JW 1989 Plasma calcium difference between man and vertebrates. Comp Biochem Physiol A Comp Physiol 93:651-654
25. Chen NX, O'Neill KD, Chen X, Moe SM 2008 Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res 23:1798-1805
26. Poole AR, Matsui Y, Hinek A, Lee ER 1989 Cartilage macromolecules and the calcification of cartilage matrix. Anat Rec 224:167-179
27. Bailey MT, Pillarisetti S, Xiao H, Vyavahare NR 2003 Role of elastin in pathologic calcification of xenograft heart valves. J Biomed Mater Res A 66:93-102
28. Dewanjee MK, Solis E, Lanker J, Mackey ST, Lombardo GM, Tidwell C, Ellefsen RD, Kaye MP 1986 Effect of diphosphonate binding to collagen upon inhibition of calcification and promotion of spontaneous endothelial cell coverage on tissue valve prostheses. ASAIO Trans 32:24-29
29. Lewinski N, Colvin V, Drezek R 2008 Cytotoxicity of Nanoparticles. Small 4:26-49
30. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W 2007 Size-Dependent Cytotoxicity of Gold Nanoparticles. Small 3:1941-1949
31. Inayat-Hussain SH, Rajab NF, Roslie H, Hussin AA, Ali AM, Annuar BO 2004 Cell death induced by hydroxyapatite on L929 fibroblast cells. Med J Malaysia 59:176-177
32. Barroug A, Kuhn LT, Gerstenfeld LC, Glimcher MJ 2004 Interactions of cisplatin with calcium phosphate nanoparticles: in vitro controlled adsorption and release. J Orthop Res 22:703-708
33. Telli C, Serper A, Dogan A, Guc D 1999 Evaluation of the cytotoxicity of calcium phosphate root canal sealers by MTT assay. J Endod 25:811-813
34. Rauschmann MA, Wichelhaus TA, Stirnal V, Dingeldein E, Zichner L, Schnettler R, Alt V 2005 Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 26:2677-2684
35. Tamai N, Myoui A, Tomita T, Nakase T, Tanaka J, Ochi T, Yoshikawa H 2002 Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo. J Biomed Mater Res 59:110-117
36. Albiar E, Holds JB 1992 Hydroxyapatite orbital implants: indications for use and nursing considerations. J Ophthalmic Nurs Technol 11:71-76
37. Mizushima Y, Ikoma T, Tanaka J, Hoshi K, Ishihara T, Ogawa Y, Ueno A 2006 Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs. J Control Release 110:260-265
38. Bouladjine A, Al-Kattan A, Dufour P, Drouet C 2009 New advances in nanocrys-talline apatite colloids intended for cellular drug delivery. Langmuir 25:12256-12265
39. Tazaki J, Murata M, Akazawa T, Yamamoto M, Ito K, Arisue M, Shibata T, Tabata Y 2009 BMP-2 release and dose-response studies in hydroxyapatite and beta-tricalcium phosphate. Biomed Mater Eng 19:141-146
40. Matsushima A, Kotobuki N, Tadokoro M, Kawate K, Yajima H, Takakura Y, Ohgushi H 2009 In vivo osteogenic capability of human mesenchymal cells cultured on hydroxyapatite and on beta-tricalcium phosphate. Artif Organs 33:474-481
41. Chang WC, Tsou HK, Chen WS, Chen CC, Shen CC 2009 Preliminary comparison of radiolucent cages containing either autogenous cancellous bone or hydroxyap-atite graft in multilevel cervical fusion. J Clin Neurosci 16:793-796
42. McCarty DJ 2008 Basic Ca phosphate and calcium oxalate crystal deposition diseases. In: Porter RS, Kaplan JL (eds) The Merck Manual Online. Merck & Co., Inc., Whitehouse Station. Available at: http://www.merck.com/mmpe/sec04/ ch035/ch035d.html. Accessed at December 5, 2009
43. Kajander EO, Ç iftçioglu N 1998 Nanobacteria: An alternative mechanism for pathogenic intra-and extracellular calcification and stone formation. Proc Natl Acad Sci USA 95:8274-8279
44. Puskás LG, Tiszlavicz L, Rázga Z, Torday LL, Krenács T, Papp JG 2005 Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biol Hung 56:233-245
45. Miller VM, Rodgers G, Charlesworth JA, Kirkland B, Severson SR, Rasmussen TE, Yagubyan M, Rodgers JC, Cockerill FR III, Folk RL, Rzewuska-Lech E, Kumar V, Farell-Baril G, Lieske JC 2004 Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 287:H1115-H1124
46. Ç iftçioglu N, McKay DS, Kajander EO 2003 Association between nanobacteria and periodontal disease. Circulation 108:e58-e59
47. Ç iftçioglu N, Björklund M, Kuorikoski K, Bergström K, Kajander EO 1999 Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 56:1893-1898
48. Kajander EO, Tahvanien E, Kuronen I, Ç iftçiog?lu N 1994 Comparison of Staph-ylococci and novel bacteria-like particles from blood. Zentralbl Bakteriol Suppl 26:147-149
49. Ç iftçiog?lu N, Pelttari A, Kajander EO 1997 Extrardinary growth phases of Nanobacteria isolated from mammalian blood. In: Hoover RB (ed) Instruments, Methods, and Missions for Astrobiology. Proceedings of SPIE, San Diego, CA, 3111:429-435
50. Ç iftçiog?lu N, Aho KM, McKay DS, Kajander EO 2007 Are apatite nanoparticles safe? Lancet 369:2078
51. Mathew G, McKay DS, Ciftçioglu N 2008 Do blood-borne calcifying nanoparticles self-propagate? Int J Nanomedicine 3:265-275
52. Kajander EO, Björklund M, Ç iftçiog?lu N 1999 Suggestions from observations on nanobacteria isolated from blood. Size Limits of Very Small Microorganisms: Proceedings of a Workshop, Steering Group on Astrobiology of the Space Studies Board, National Research Council, Washington DC, pp 50-55
53. Björklund M, Ç iftçiog?lu N, Kajander EO 1998 Extraordinary survival of nanobac-teria under extreme conditions. In: Hoover RB (ed) Instruments, Methods, and Missions for Astrobiology. Proceedings of SPIE, San Jose, CA, 3441:123-129
54. Çiftçiog?lu N, McKay DS, Mathew G, Kajander EO 2006 Nanobacteria: Nanobac-teria: fact or fiction? Characteristics, detection, and medical importance of novel self-replicating, calcifying nanoparticles. J Investig Med 54:385-394
55. Ç iftçiog?lu N, Miller-Hjelle MA, Hjelle JT, Kajander EO 2002 Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother 46:2077-2086 (Pubitemid 34665900)
56. Ç iftçiog?lu N 2002 Kidney stone formation: an infectious disease? Japanese Journal of Urological Surgery 15:228-232
57. Kajander EO, Çiftçiog?lu N, Aho K, Garcia-Cuerpo E 2003 Characteristics of Nanobacteria and their possible role in stone formation. Urol Res 31:47-54
58. Shiekh FA, Khullar M, Singh SK 2006 Lithogenesis: induction of renal calcifications by nanobacteria. Urol Res 34:53-57 (Pubitemid 43234715)
59. Ciftçiog?lu N, Vejdani K, Lee O, Mathew G, Aho KM, Kajander EO, McKay DS, Jones JA, Stoller ML 2008 Association between Randall's plaque and calcifying nanoparticles. Int J Nanomedicine 3:105-115 (Pubitemid 351517081)
60. Wen Y, Li YG, Yang ZL, Wang XJ, Wei H, Liu W, Miao XY, Wang QW, Huang SF, Yang J, Kajander EO, Ç iftçioglu N 2005 Detection of nanobacteria in serum, bile and gallbladder mucosa of patients with cholecystolithiasis. Chin Med J 118:421-424 (Pubitemid 40378581)
61. Wen Y, Li YG, Yang ZL, Wang XJ, Wei H, Liu W, Tan AL, Miao XY, Wang QW, Huang SF, Kajander EO, Ç iftçiog?lu N 2003 Nanobacteria in serum, bile and gallbladder mucosa of cholecystolithiasis patients. Zhonghua Wai Ke Za Zhi 41:267-270
62. Çiftçioglu N, Çiftçioglu V, Vali H, Turcott E, Kajander EO 1998 Sedimentary rocks in our mouth: Dental pulp stones made by Nanobacteria. In: Hoover RB (ed) Instruments, Methods, and Missions for Astrobiology. Proceedings of SPIE 3441:130-135
63. Zhang SM, Tian F, Jiang XQ, Li J, Xu C, Guo XK, Zhang FQ 2009 Evidence for calcifying nanoparticles in gingival crevicular fluid and dental calculus in peri-odontitis. J Periodontol 80:1462-1470
64. Zeng JF, Zhang W, Jiang HW, Ling JQ 2006 [Isolation, cultivation and initial identification of Nanobacteria from dental pulp stone.] Zhonghua Kou Qiang Yi Xue Za Zhi 41:498-501
65. Zhou Z, Hong L, Shen X, Rao X, Jin X, Lu G, Li L, Xiong E, Li W, Zhang J, Chen Z, Pan J, Song B 2008 Detection of nanobacteria infection in type III prostatitis. Urology 71:1091-1095. Erratum in: Urology 72:723 (Pubitemid 351763790)
66. Wood HM, Shoskes DA 2006 The role of nanobacteria in urologic disease. World J Urol 24:51-54
67. Shoskes DA, Thomas KD, Gomez E 2005 Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol 173:474-477
68. Hjelle JT, Miller-Hjelle MA, Poxton IR, Kajander EO, Ç iftçiog?lu N 2000 Endo-toxin and nanobacteria in polycystic kidney disease. Kidney Int 57:2360-2374 (Pubitemid 30340735)
69. Kajander EO, Ç iftçiog?lu N, Miller-Hjelle MA, Hjelle JT 2001 Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease. Curr Opin Nephrol Hypertens 10:445-452 (Pubitemid 32424037)
70. Hudelist G, Singer CF, Kubista E, Manavi M, Mueller R, Pischinger K, Czerwenka K 2004 Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. Histopathology 45:633-637 (Pubitemid 40029824)
71. Wainwright M 1999 Nanobacteria and associated 'elementary bodies' in human disease and cancer. Microbiology 145:2623-2624
72. Ç iftçioglu N, Kajander EO 1998 Interaction of nanobacteria with cultured mammalian cells. Pathophysiology 4:259-270 (Pubitemid 28085561)
73. Åkerman KK, Kuikka JT, Ç iftçioglu N, Parkkinen J, Bergström KA, Kuronen I, Kajander EO 1997 Radiolabeling and in vivo distribution of nanobacteria in rabbit. In: Hoover RB (ed) Instruments, Methods, and Missions for Astrobiology. The International Society for Optical Engineering, Proceedings of SPIE, San Diego, CA, 3111:436-442
74. Randall A 1937 The origin and growth of renal calculi. Ann Surg 105:1009-1027
75. Matlaga BR, Coe FL, Evan AP, Lingeman JE 2007 The role of Randall's palques in the pathogenesis of calcium stones. J Urol 177:31-38 (Pubitemid 44895331)
76. Burton EM, Hanna JD, Mercado-Deane MG 1995 Nephrocalcinosis in a child with autosomal dominant polycystic kidney disease and a prolapsing ectopic ureterocele. Pediatr Radiol 25:462-465
77. Muezzinoglu B, Gurbuz Y 2001 Stromal microcalcification in prostate. Malays J Pathol 23:31-33
78. Anim JT, Kehinde EO, Prasad A, Prasad A, Mojiminiyi OA, Ali Y, Al-Awadi KA 2006 Relationship between serum prostate specific antigen and the pattern of inflammation in both benign and malignant prostatic disease in Middle Eastern men. Int Urol Nephrol 38:27-32 (Pubitemid 43299810)
79. Torres Ramirez C, Aguilar Ruiz J, Zuluaga Gomez A 1981 Ultrastructure of primary or endogenous prostatic calculi. Scanning electron microscopic study. Arch Esp Urol 34:13-22 (Pubitemid 11021912)
80. Zhang QH, Lu GS, Shen XC, Zhou ZS, Fang Q, Zhang X, Li LK, Jin XY, Song B 2009 Nanobacteria may be linked to testicular microlithiasis in infertility. J Androl, in press
81. Maniscalco BS, Taylor KA 2004 Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. Pathophysiology 11:95-101
82. Hu YR, Zhao Y, Sun YW, Lü WD, Liu ZL, Li JM, Wu ZS, Tang H, Gao F, Zhou XM 2009 Detection of nanobacteria-like material from calcified cardiac valves with rheumatic heart disease. Cardiovasc Pathol, in press
83. Bellah RD, Zawodniak L, Librizzi RJ, Harris MC 1992 Idiopathic arterial calcification of infancy: Prenatal and postnatal effects of therapy in an infant. J Pediatr 121:930-933
84. Sedivy R, Battistutti WB 2003 Nanobacteria promote crystallization of psammoma bodies in ovarian cancer. APMIS 111:951-954 (Pubitemid 37352613)
85. Jelic TM, Malas AM, Groves SS, Jin B, Mellen PF, Osborne G, Roque R, Rosencrance JG, Chang HH 2004 Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure. South Med J 97:194-198 (Pubitemid 38222828)
86. Sommer AP, Pavlath AE 2005 Primordial proteins and HIV. J Proteome Res 4:633-636
87. Pretorius AM, Sommer AP, Aho KM, Kajander EO 2004 HIV and nanobacteria. HIV Med 5:391-393
88. Sommer AP 2004 Could reduced bone mineral densities in HIV be caused by nanobacteria? J Proteome Res 3:670-672
89. Miller-Hjelle MA, Hjelle JT, Ç iftçiog?lu N, Kajander EO 2003 Nanobacteria: methods for growth and identification of this recently discovered calciferous agent. In: Olson WP (eds). Rapid Analytical Microbiology, the Chemistry and Physics of Microbial Identification. Davis Horwood International Publishing, Surrey, United Kingdom, pp 297-312
90. Garcia-Cuerpo E, Kajander EO, Ç iftçiog?lu N, Castellano FJ, Correa C, Gonzales J, Mampaso F, Liano F, De Gabiola EG, Berrilero YA 2000 Nanobacteria: un modelo de neo-litogenesis experimental. Arch Esp Urol 53:291-303
91. Schwartz MK, Lieske JC, Hunter LW, Miller VM 2009 Systemic injection of planktonic forms of mammalian-derived nanoparticles alters arterial response to injury in rabbits. Am J Physiol Heart Circ Physiol 296:H1434-H1441
92. Ç iftçiog?lu N, Björklund M, Kajander EO 1998 Stone formation and calcification by nanobacteria in human body. In: Hoover RB (ed) Instruments, Methods, and Missions for Astrobiology. Proceedings of SPIE, San Jose, CA, 3441:105-111
93. Kajander EO, Kuronen I, Åkerman K, Pelttari A, Ç iftçiog?lu N 1997 Nanobacteria from blood, the smallest culturable autonomously replicating agent on earth. In: Hoover RB (ed) Instruments, Methods, and Missions for the Investigation of Extraterrestrial Microorganisms, Proceedings of SPIE, San Diego, CA, 3111:420-428
94. Schwartz MK, Hunter LW, Huebner M, Lieske JC, Miller VM 2009 Characterization of biofilm formed by human-derived nanoparticles. Nanomedicine 4:931-941
95. Evan AP, Bledsoe SB, Connors BA, Deng L, Liang L, Shao C, Fineberg NS, Grynpas MD, Stambrook PJ, Youzhi S, Sahota A, Tischfield JA 2001 Sequential analysis of kidney stone formation in the Aprt knockout mouse. Kidney Int 60:910-923 (Pubitemid 34205791)
96. Naito Y, Ohtawara Y, Kageyama S, Nakano M, Ichiyama A, Fujita M, Suzuki K, Kawabe K, Kino I 1997 Morphological analysis of renal cell culture models of calcium phosphate stone formation. Urol Res 25:59-65 (Pubitemid 27141805)
97. Çiftçioglu N, Haddad RS, Golden DC, Morrison DR, McKay DS 2005 A potential cause for kidney stone formation during space flights: enhanced growth of nanobac-teria in microgravity. Kidney Int 67:483-491 (Pubitemid 40139840)
98. Becker W, Marxen J, Epple M, Reelsen O 2000 Influence of microgravity on crystal formation in biomineralization. J Appl Physiol 89:1601-1607
99. Whitson PA, Pietrzyk RA, Sams CF 2001 Urine volume and its effects on renal stone risk in astronauts. Aviat Space Environ Med 72:368-372
100. Pak CY, Hill K, Cintron NM, Huntoon C 1989 Assessing applicants to the NASA flight program for their renal stone-forming potential. Aviat Space Environ Med 60:157-161 (Pubitemid 19053900)
101. McCarthy ID 2005 Fluid shifts due to microgravity and their effects on bone: a review of current knowledge. Ann Biomed Eng 33:95-103
102. Jones JA, Jennings R, Pietryzk R, Ciftcioglu N, Stepaniak P 2005 Genitourinary issues during spaceflight: a review. Int J Impot Res 17:S64-S67 (Pubitemid 43049379)
103. Jones JA, Ç iftçiog?lu N, Schmid JF, Barr YR, Griffith D 2009 Calcifying nanopar-ticles (nanobacteria): an additional potential factor for urolithiasis in space flight crews. Urology 73:210.e11-210.e13
104. Young JD, Martel J, Young L, Wu CY, Young A, Young D 2009 Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis. PLoS One 4:e4417
105. Martel J, Young JD 2008 Purported nanobacteria in human blood as calcium carbonate nanoparticles. Proc Natl Acad Sci USA 105:5549-5554 (Pubitemid 351753900)
106. Raoult D, Drancourt M, Azza S, Nappez C, Guieu R, Rolain JM, Fourquet P, Campagna B, La Scola B, Mege JL, Mansuelle P, Lechevalier E, Berland Y, Gorvel JP, Renesto P 2008 Nanobacteria are mineralo fetuin complexes. PLoS Pathog 4:e41 (Pubitemid 351340707)
107. Cisar JO, Xu DQ, Thompson J, Swaim W, Hu L, Kopecko DJ 2000 An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci USA 97:11511-11515
108. Maniloff J, Nealson KH, Psenner R, Loferer M, Folk RL 1997 Nannobacteria: size limits and evidence. Science 276:1773-1776
109. Glass JI, Assad-Garcia N, Alperovich N, Yooseph S, Lewis MR, Maruf M, Hutchison CA 3rd, Smith HO, Venter JC 2006 Essential genes of a minimal bacterium. Proc Natl Acad Sci USA 103:425-430 (Pubitemid 43122417)
110. Cranton E Rest in peace nanobacteria, you were not alive after all. Available at: http://www.drcranton.com/nanobacteria.htm. Accessed December 5, 2009
111. Vali H, McKee MD, Ç iftçiog?lu N, Sears SK, Plows FL, Chevet E, Ghiasi P, Plavsic M, Kajander EO, Zare RN 2001 Nanoforms: a new type of protein-associated mineralization. Geochim Cosmochim Acta 65:63-74
112. Miller VM, Hunter LW, Chu K, Kaul V, Squillace PD, Lieske JC, Jayachandran M 2009 Biologic nanoparticles and platelet reactivity. Nanomed 4:725-733
113. Kumar V, Farell G, Harrington S, Fitzpatrick L, Rzewuska E, Miller VM, Lieske JC 2006 Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles. J Investig Med 54:412-424
114. Shiekh FA, Miller VM, Lieske JC 2009 Do calcifying nanoparticles promote nephrolithiasis? A review of the evidence. Clin Nephrol 71:1-8
115. Sommer AP, Hassinen HI, Kajander EO 2002 Light induced replication of nanobacteria: A preliminary report. J Clin Laser Med Surg 20:241-244
116. Bullard T, Freudenthal J, Avagyan S, Kahr B 2007 Test of Cairns-Smith's 'crystals-as-genes' hypothesis. Faraday Discuss 136:231-245; discussion 309-328
117. Pereto J 2005 Controversies on the origin of life. Int Microbiol 8:23-31
118. Pennisi E 2007 DNA study forces rethink of what it means to be a gene. Science 316:1556-1557
119. Shapiro R 2006 Small molecule interactions were central to the origin of life. Q Rev Biol 81:105-125
120. Zhou HD, Li GY, Yang YX, Li XL, Sheng SR, Zhang WL, Zhao J 2006 Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopha-ryngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Mol Immunol 43:1864-1871
121. Ç iftçiog?lu N, Kuronen I, Åkerman K, Hiltunen E, Laukkanen J, Kajander EO 1997 A new potential threat in antigen and antibody products: nanobacteria. In: Brown F, Burton D, Doherty P, Mekalanos J, Norrby E (eds) Vaccines 97. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp 99-103